Literature DB >> 28081449

Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy.

Tomoko Nakagami1, Kanako Takahashi2, Chikako Suto3, Junko Oya4, Yuki Tanaka4, Moritoshi Kurita4, Chisato Isago4, Yukiko Hasegawa4, Arata Ito4, Yasuko Uchigata4.   

Abstract

AIMS: As retinopathy is used as a defining threshold of diabetes, we assessed the glycated hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) values associated with an increased risk of 5-year incidence of retinopathy.
METHODS: We studied HbA1c, FPG, and optic fundus findings of 2605 individuals without previously diagnosed diabetes annually during a 5-year period. Retinopathy was examined using non-mydriatic, 45° digital fundus photography. Baseline levels were stratified as <5.3 [34], 5.3-5.6 [34-38], 5.7-6.0 [39-42], 6.1-6.4 [43-47], and ⩾6.5% [48mmol/mol] for HbA1c and <5.0, 5.0-5.5, 5.6-6.0, 6.1-6.9, and ⩾7.0mmol/L for FPG. Cox proportional hazard models were used to analyze hazard ratios (HRs) associated with HbA1c or FPG for incident retinopathy.
RESULTS: During a total of 11845 person-years, we identified 50 (1.9%) cases of incident retinopathy. The adjusted HRs for incident retinopathy associated with a one-standard deviation increase in HbA1c and FPG were 1.2 (95% confidence intervals: 1.1-1.4) and 1.2 (1.1-1.4), respectively. These HRs were significantly higher for a HbA1c level ⩾6.5% (48mmol/mol) (3.4 [1.1-10.2]) or FPG level ⩾7.0mmol/L (3.6 [1.1-11.6]) than for a HbA1c level <5.3% (34mmol/mol) or FPG level <5.0mmol/L.
CONCLUSIONS: A HbA1c value of 6.5% (48mmol/mol) and FPG value of 7.0mmol/L might be proper as diabetes diagnostic thresholds that indicate a high risk of future retinopathy.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Diagnostic criteria; Fasting plasma glucose; HbA1c; Incidence; Retinopathy

Mesh:

Substances:

Year:  2016        PMID: 28081449     DOI: 10.1016/j.diabres.2016.12.013

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Diffusion-weighted imaging of injuries to the visual centers of the brain in patients with type 2 diabetes and retinopathy.

Authors:  Ming Liang; Xing Chen; Feng Xue; Lingna Meng; Yunfeng Cong
Journal:  Exp Ther Med       Date:  2017-06-12       Impact factor: 2.447

2.  Influencing factors for peripheral and posterior lesions in mild non-proliferative diabetic retinopathy-the Kailuan Eye Study.

Authors:  Mo-Chi Yang; Xiao-Bo Zhu; Ya-Xing Wang; Shou-Ling Wu; Qian Wang; Yan-Ni Yan; Xuan Yang; Jing-Yan Yang; Meng-Xi Chen; Ya-Hui Lei; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

3.  A comparison in the ability to detect diabetic retinopathy between fasting plasma glucose and HbA1c levels in a longitudinal study.

Authors:  Yumi Matsushita; Tetsuji Yokoyama; Norio Takeda; Naotatsu Katai; Natsuyo Yoshida-Hata; Yosuke Nakamura; Shuichiro Yamamoto; Mitsuhiko Noda; Tetsuya Mizoue; Toru Nakagawa
Journal:  Endocrinol Diabetes Metab       Date:  2020-11-04

4.  Predictive model and risk analysis for diabetic retinopathy using machine learning: a retrospective cohort study in China.

Authors:  Wanyue Li; Yanan Song; Kang Chen; Jun Ying; Zhong Zheng; Shen Qiao; Ming Yang; Maonian Zhang; Ying Zhang
Journal:  BMJ Open       Date:  2021-11-26       Impact factor: 2.692

5.  A Comparison of the Association of Fasting Plasma Glucose and HbA1c Levels with Diabetic Retinopathy in Japanese Men.

Authors:  Yumi Matsushita; Norio Takeda; Yosuke Nakamura; Natsuyo Yoshida-Hata; Shuichiro Yamamoto; Mitsuhiko Noda; Tetsuji Yokoyama; Tetsuya Mizoue; Toru Nakagawa
Journal:  J Diabetes Res       Date:  2020-10-31       Impact factor: 4.011

6.  Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China.

Authors:  Yanyun Li; Huiru Jiang; Minna Cheng; Weiyuan Yao; Hua Zhang; Yan Shi; Wanghong Xu
Journal:  BMJ Open Diabetes Res Care       Date:  2020-08

7.  Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.

Authors:  Alexandra E Butler; Emma English; Eric S Kilpatrick; Linda Östlundh; Hiam S Chemaitelly; Laith J Abu-Raddad; K George M M Alberti; Stephen L Atkin; W Garry John
Journal:  Acta Diabetol       Date:  2020-11-03       Impact factor: 4.280

8.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.